The publication, titled “ Comparative characterization of Cas12f orthologs reveals mechanistic features underlying enhanced genome editing efficiency” highlights the potential of MG119-28 (formally ...

This guidance emphasises the potential of NGS methods in mitigating safety risks associated with therapies incorporating ...

The US Food and Drug Administration released a draft guidance document on Tuesday with recommendations for using ...

The draft guidance supports the agency’s new pathway designed to speed up the development of custom gene therapies.

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling ...

The genome has thousands of genes that code for proteins, which help carry out many of the cell's important functions. But ...

A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.

Gene‑edited HPSCs programmed to make therapeutic antibodies and proteins show long‑lasting, boostable immunity in mouse models.

Genome editing is a powerful biotechnology tool that allows scientists to make precise changes to an organism's DNA. It involves the use of specialized enzymes, known as engineered nucleases or ...

Imagination pairs with plant breeding innovation using tools such as gene editing and cyber agriculture to redefine ...